180 related articles for article (PubMed ID: 3540495)
1. Antigens of Mycobacterium leprae in urine during treatment of patients with lepromatous leprosy.
Olcén P; Harboe M; Warndorff van Diepen T
Lepr Rev; 1986 Dec; 57(4):329-40. PubMed ID: 3540495
[No Abstract] [Full Text] [Related]
2. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
3. A method for the detection of M. leprae antigens in urine of leprosy patients by gel diffusion and gel electrophoretic techniques and significance in diagnosis.
Patil SA; Katoch K; Sengupta U
Acta Leprol; 1991; 7(5):403-7. PubMed ID: 1805496
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium leprae particle agglutination in diagnosis and monitoring of treatment of leprosy.
Kampirapap K
J Med Assoc Thai; 1999 Oct; 82(10):1020-4. PubMed ID: 10561966
[TBL] [Abstract][Full Text] [Related]
5. Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy.
Melsom R; Naafs B; Harboe M; Closs O
Lepr Rev; 1978 Mar; 49(1):17-29. PubMed ID: 347205
[No Abstract] [Full Text] [Related]
6. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
Smelt AH; Rees RH; Liew FY
Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
8. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment of leprosy].
López-Antuñano FJ
Salud Publica Mex; 1998; 40(1):66-75. PubMed ID: 9580503
[No Abstract] [Full Text] [Related]
10. Monitoring the effects of preventive therapy in the Federated States of Micronesia.
Cho SN; Walsh GP; Brennan PJ
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S19-22. PubMed ID: 10700932
[No Abstract] [Full Text] [Related]
11. Antigens of Mycobacterium leprae and anti-M. leprae antibodies in the urine of leprosy patients.
Olcén P; Harboe M; Warndorff T; Belehu A
Lepr Rev; 1983 Sep; 54(3):203-16. PubMed ID: 6355725
[No Abstract] [Full Text] [Related]
12. In vitro activation of neutrophils by suspensions of Mycobacterium leprae.
Goihman-Yahr M; Rodriguez-Ochoa G; Aranzazu N; Pinardi ME; de Gomez ME; Ocanto A; Convit J
Int J Lepr Other Mycobact Dis; 1979 Dec; 47(4):570-4. PubMed ID: 122626
[TBL] [Abstract][Full Text] [Related]
13. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
[TBL] [Abstract][Full Text] [Related]
14. The influence of antimycobacterial chemotherapy on delayed hypersensitivity skin-test reactions in leprosy patients.
Cree IA; Smith WC; Rees RJ; Beck JS
Lepr Rev; 1988 Jun; 59(2):145-51. PubMed ID: 3073285
[No Abstract] [Full Text] [Related]
15. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG.
Vikerfors T; Olcén P; Wiker H; Watson JD
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188
[TBL] [Abstract][Full Text] [Related]
16. A comparative and combinatorial study on two serological assays for detection of Mycobacterium leprae infection.
Parkash O; Girdhar BK
Acta Leprol; 2001-2002; 12(2):63-9. PubMed ID: 12136738
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide does not modify the ability of cells in leprosy patients to incorporate [3H]-thymidine when incubated with M. leprae antigens.
Tadesse A; Taye E; Sandoval F; Shannon EJ
Lepr Rev; 2003 Sep; 74(3):206-14. PubMed ID: 14577465
[TBL] [Abstract][Full Text] [Related]
18. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).
Rada E; Ulrich M; Aranzazu N; Rodriguez V; Centeno M; Gonzalez I; Santaella C; Rodriguez M; Convit J
Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484
[TBL] [Abstract][Full Text] [Related]
19. Detection of a Mycobacterium leprae cell wall antigen in the urine of untreated and treated patients.
Sharma VK; Kaur S; Vaishnavi C; Agnihotri N; Kaur I; Ganguly NK
Lepr Rev; 1992 Mar; 63(1):28-35. PubMed ID: 1569813
[TBL] [Abstract][Full Text] [Related]
20. [Hansen's disease: case report and review of literature].
Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
